A multicenter, randomized controlled comparison of three renutrition strategies for the management of moderate acute malnutrition among children aged from 6 to 24 months (the MALINEA project)
Authors:
- Muriel VrayMVMuriel Vray
- Boris G. HedibleBHBoris G. Hedible
- Pierrick AdamPAPierrick Adam
- Laura TondeurLTLaura Tondeur
- Alexandre ManirazikaAMAlexandre Manirazika
- Rindra RandremananaRRRindra Randremanana
- Halima MainassaraHMHalima Mainassara
- André BriendABAndré Briend
- Cecile ArtaudCACecile Artaud
- Cassandre von PlatenCPCassandre von Platen
- Mathias AltmannMAMathias Altmann
- Ronan JambouRonan Jambou
Open Access
- 4 December 2018
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 19 (1) , 666
Abstract
The aim of this open-label, randomized controlled trial conducted in four African countries (Madagascar, Niger, Central African Republic, and Senegal) is to compare three strategies of renutrition for moderate acute malnutrition (MAM) in children based on modulation of the gut microbiota with enriched flours alone, enriched flours with prebiotics or enriched flours coupled with antibiotic treatment. To be included, children aged between 6 months and 2 years are preselected based on mid-upper-arm circumference (MUAC) and are included based on a weight-for-height Z-score (WHZ) between − 3 and − 2 standard deviations (SD). As per current protocols, children receive renutrition treatment for 12 weeks and are assessed weekly to determine improvement. The primary endpoint is recovery, defined by a WHZ ≥ − 1.5 SD after 12 weeks of treatment. Data collected include clinical and socioeconomic characteristics, side effects, compliance and tolerance to interventions. Metagenomic analysis of gut microbiota is conducted at inclusion, 3 months, and 6 months. The cognitive development of children is evaluated in Senegal using only the Developmental Milestones Checklist II (DMC II) questionnaire at inclusion and at 3, 6, and 9 months. The data will be correlated with renutrition efficacy and metagenomic data. This study will provide new insights for the treatment of MAM, as well as original data on the modulation of gut microbiota during the renutrition process to support (or not) the microbiota hypothesis of malnutrition. ClinicalTrials.gov, ID: NCT03474276 Last update 28 May 2018.Keywords
Funding Information
- Ministry of Economic Affairs and Employment (2101375618)
- Action Contre La Faim
This publication has 99 references indexed in Scilit:
- Microbial Endocrinology in the Microbiome-Gut-Brain Axis: How Bacterial Production and Utilization of Neurochemicals Influence BehaviorPLOS Pathogens, 2013
- Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III – convergence toward clinical trialsGut Pathogens, 2013
- Gastrointestinal function development and microbiotaItalian Journal of Pediatrics, 2013
- Metagenomic profile of gut microbiota in children during cholera and recoveryGut Pathogens, 2013
- Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese womenGut, 2012
- Sentinel site community surveillance of mortality and nutritional status in southwestern Central African Republic, 2010Population Health Metrics, 2012
- Human gut microbiome viewed across age and geographyNature, 2012
- Tolerance and Safety Evaluation in a Large Cohort of Healthy Infants Fed an Innovative Prebiotic Formula: A Randomized Controlled TrialPLOS ONE, 2011
- Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural AfricaProceedings of the National Academy of Sciences of the United States of America, 2010
- A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin, a Nonabsorbable Antibiotic, in the Treatment of Tropical EnteropathyAmerican Journal of Gastroenterology, 2009